Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-19

Clinical Trial Update: Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing evaluation of autologous bone marrow transplant in insulin-dependent diabetes patients across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous bone marrow transplant

Snippet

Sponsor: Global Cell Med | Conditions: Diabetes Mellitus Progression, Diabetes Complications | Phase 2, Phase 3 | Status: UNKNOWN